Bey-Douglas LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41M Buy
9,845
+7,623
+343% +$1.78M 2.1% 17
2025
Q4
$460K Buy
2,222
+94
+4% +$18.6K 0.37% 28
2025
Q3
$395K Buy
2,128
+85
+4% +$14.6K 0.29% 33
2025
Q2
$312K Buy
2,043
+104
+5% +$16K 0.19% 34
2025
Q1
$322K Buy
1,939
+48
+3% +$7.51K 0.29% 29
2024
Q4
$273K Buy
1,891
+4
+0.2% +$620 0.24% 30
2024
Q3
$306K Buy
1,887
+58
+3% +$9.24K 0.27% 30
2024
Q2
$273K Buy
1,829
+3
+0.2% +$446 0.25% 31
2024
Q1
$289K Buy
1,826
+81
+5% +$12.9K 0.28% 31
2023
Q4
$273K Buy
+1,745
New +$268K 0.28% 31

Other funds holding JNJ

Bey-Douglas LLC's JNJ Position: Q1 2026 in Review

Bey-Douglas LLC increased its Johnson & Johnson (JNJ) stake by 343% in Q1 2026, buying an estimated $1.78M and bringing the position to 9,845 shares worth $2.41M. The position accounts for 2.1% of the portfolio, ranked #17.

Bey-Douglas LLC first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bey-Douglas LLC held 9,845 shares of Johnson & Johnson worth $2.41M as of Q1 2026.
  • Bey-Douglas LLC bought 7,623 Johnson & Johnson shares in Q1 2026, an estimated $1.78M.
  • Johnson & Johnson made up 2.1% of Bey-Douglas LLC's portfolio in Q1 2026, its #17 holding.
  • Bey-Douglas LLC first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bey-Douglas LLC's 13F filing for Q1 2026, filed 12 May 2026.